Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4670)
All Articles published online
|
Nov 10, 2011 (publication date) through Jun 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mello RA, Marques DS, Medeiros R, Araújo AM. Epidermal growth factor receptor and K-Ras in non-small cell lung cancer-molecular pathways involved and targeted therapies. World J Clin Oncol 2011; 2(11): 367-376 [PMID: 22087435 DOI: 10.5306/wjco.v2.i11.367] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v2/i11/367.htm |
| Number | Citing Articles |
| 1 |
Yuan-Yuan Lei, Wei-Jia Wang, Jin-Hong Mei, Chun-Liang Wang. Mitogen-Activated Protein Kinase Signal Transduction in Solid Tumors. Asian Pacific Journal of Cancer Prevention 2014; 15(20): 8539 doi: 10.7314/APJCP.2014.15.20.8539
|
| 2 |
Ramon Andrade de Mello, Michael Luis, António Araújo, Rui Manuel Reis, Venceslau Hespanhol. Biochemical Basis and Therapeutic Implications of Angiogenesis. 2013; : 381 doi: 10.1007/978-1-4614-5857-9_20
|
| 3 |
Mirjana Miladinović, Ljiljana Vučković, Aleksandra Klisic. Comparison of Dako HercepTest and Ventana PATHWAY anti-HER2 (4B5) tests and their correlation with silver in situ hybridization in lung adenocarcinoma. Open Medicine 2021; 16(1): 1503 doi: 10.1515/med-2021-0366
|
| 4 |
Xuerong Liu, Yan Wang, Jinglong Zhao. MicroRNA-337 inhibits colorectal cancer progression by directly targeting KRAS and suppressing the AKT and ERK pathways. Oncology Reports 2017; 38(5): 3187 doi: 10.3892/or.2017.5997
|
| 5 |
Ramon Andrade De Mello, António Araújo. Epidermal growth factor receptor mutation frequency and non-small cell lung cancer management: implication for treatment choices. Clinics 2012; 67(11): 1349 doi: 10.6061/clinics/2012(11)22
|
| 6 |
Luguo Sun, Liyan Sui, Xianling Cong, Kejuan Ma, Xiaobo Ma, Yanxin Huang, Cong Fan, Xueqi Fu, Kewei Ma. Low incidence of IL6ST (gp130) mutations in exon 6 in lung cancer of a Chinese cohort. Cancer Genetics 2014; 207(7-8): 291 doi: 10.1016/j.cancergen.2014.07.003
|
| 7 |
Shin Saito, Fernando Espinoza-Mercado, Hui Liu, Naohiro Sata, Xiaojiang Cui, Harmik J. Soukiasian. Current status of research and treatment for non-small cell lung cancer in never-smoking females. Cancer Biology & Therapy 2017; 18(6): 359 doi: 10.1080/15384047.2017.1323580
|
| 8 |
Ramon Andrade De Mello, Michael Luis, António Araújo, Rui Manuel Reis, Venceslau Hespanhol. Biochemical Basis and Therapeutic Implications of Angiogenesis. 2017; : 217 doi: 10.1007/978-3-319-61115-0_10
|
| 9 |
Yasuhiro Tezuka, Shunsuke Endo, Aya Matsui, Atsuko Sato, Katsuyo Saito, Kentaro Semba, Masafumi Takahashi, Takashi Murakami. Potential anti-tumor effect of IFN-λ2 (IL-28A) against human lung cancer cells. Lung Cancer 2012; 78(3): 185 doi: 10.1016/j.lungcan.2012.09.005
|
| 10 |
JIN-MEI XU, YAN ZHOU, LONG GAO, SHU-XIAN ZHOU, WEI-HUA LIU, XIAO-AN LI. Stromal interaction molecule 1 plays an important role in gastric cancer progression. Oncology Reports 2016; 35(6): 3496 doi: 10.3892/or.2016.4704
|
| 11 |
Xiao‑Han Yuan, Jie Yang, Xin‑Yue Wang, Xiao‑Ling Zhang, Ting‑Ting Qin, Kai Li. Association between EGFR/KRAS mutation and expression of VEGFA, VEGFR and VEGFR2 in lung adenocarcinoma. Oncology Letters 2018; doi: 10.3892/ol.2018.8901
|
| 12 |
Ramon Andrade de Mello, Pedro Madureira, Liliana S Carvalho, António Araújo, Mary O‘Brien, Sanjay Popat.
EGFR
and
KRAS
Mutations, and
ALK
Fusions: Current Developments and Personalized Therapies for Patients with Advanced Non-Small-Cell Lung Cancer
. Pharmacogenomics 2013; 14(14): 1765 doi: 10.2217/pgs.13.177
|
| 13 |
Ramon Andrade de Mello, Mónica Ferreira, Filipa Soares-Pires, Sandra Costa, João Cunha, Pedro Oliveira, Venceslau Hespanhol, Rui Manuel Reis, Zhengdong Zhang. The Impact of Polymorphic Variations in the 5p15, 6p12, 6p21 and 15q25 Loci on the Risk and Prognosis of Portuguese Patients with Non-Small Cell Lung Cancer. PLoS ONE 2013; 8(9): e72373 doi: 10.1371/journal.pone.0072373
|
| 14 |
Hala Aziz Shokralla, Mohamed Rahouma. Prognostic Clinico-Pathological Features of 99 Cases Advanced Non-Small Cell Lung Cancer—Egyptian National Cancer Institute. Advances in Lung Cancer 2015; 4(03): 29 doi: 10.4236/alc.2015.43005
|
| 15 |
Ramon Andrade De Mello. Metastatic Melanoma and Vemurafenib: Novel Approaches. Rare Tumors 2012; 4(2): 96 doi: 10.4081/rt.2012.e31
|
| 16 |
HONG-YING LIAO, GUI-PING WANG, SHAO-HONG HUANG, YUN LI, SONG-WANG CAI, JIAN ZHANG, HUI-GUO CHEN, WEI-BIN WU. HIF-1α silencing suppresses growth of lung adenocarcinoma A549 cells through induction of apoptosis. Molecular Medicine Reports 2014; 9(3): 911 doi: 10.3892/mmr.2014.1910
|
| 17 |
Kirtee Raparia, Celina Villa, Malcolm M. DeCamp, Jyoti D. Patel, Minesh P. Mehta. Molecular Profiling in Non–Small Cell Lung Cancer: A Step Toward Personalized Medicine. Archives of Pathology & Laboratory Medicine 2013; 137(4): 481 doi: 10.5858/arpa.2012-0287-RA
|
| 18 |
Ramon Andrade de Mello, Sandra Gerós, Marcos Pantarotto Alves, Filipa Moreira, Isabel Avezedo, José Dinis, Apar Kishor Ganti. Cetuximab Plus Platinum-Based Chemotherapy in Head and Neck Squamous Cell Carcinoma: A Retrospective Study in a Single Comprehensive European Cancer Institution. PLoS ONE 2014; 9(2): e86697 doi: 10.1371/journal.pone.0086697
|
| 19 |
Ramon Andrade de Mello, Mónica Ferreira, Sandra Costa, Bruno Marques Costa, Filipa Soares Pires, Inês Neves, Maria Inês Almeida, João Cunha, Pedro Oliveira, Venceslau Hespanhol, Rui Manuel Reis. Association between EGF +61 genetic polymorphisms and non-small cell lung cancer increased risk in a Portuguese population: a case–control study. Tumor Biology 2012; 33(5): 1341 doi: 10.1007/s13277-012-0382-7
|
| 20 |
Lihua Huang, Liwu Fu. Mechanisms of resistance to EGFR tyrosine kinase inhibitors. Acta Pharmaceutica Sinica B 2015; 5(5): 390 doi: 10.1016/j.apsb.2015.07.001
|
| 21 |
Ramon Andrade de Mello, Filipa Soares Pires, Dânia Sofia Marques, Júlio Oliveira, Ana Rodrigues, Marta Soares, Isabel Azevedo, Ana Peixoto, Catarina Santos, Carla Pinto, Venceslau Hespanhol, Manuel R Teixeira, Teresina Amaro, Henrique Queiroga, António Araújo. EGFR exon mutation distribution and outcome in non-small-cell lung cancer: a Portuguese retrospective study. Tumor Biology 2012; 33(6): 2061 doi: 10.1007/s13277-012-0465-5
|
| 22 |
Cecilia Lopez Sambrooks, Marta Baro, Amanda Quijano, Azeet Narayan, Wei Cui, Patricia Greninger, Regina Egan, Abhijit Patel, Cyril H. Benes, W. Mark Saltzman, Joseph N. Contessa. Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase Inhibitors. Cancer Research 2018; 78(17): 5094 doi: 10.1158/0008-5472.CAN-18-0505
|
| 23 |
Mónica Gomes, Ana Luísa Teixeira, Ana Coelho, António Araújo, Rui Medeiros. Inflammation and Cancer. Advances in Experimental Medicine and Biology 2014; 816: 1 doi: 10.1007/978-3-0348-0837-8_1
|
| 24 |
Pedro Madureira, Ramon Andrade de Mello, Alessandro de Vasconcelos, Yan Zhang. Immunotherapy for lung cancer: for whom the bell tolls?. Tumor Biology 2015; 36(3): 1411 doi: 10.1007/s13277-015-3285-6
|
| 25 |
Jiurong Li, Aiping Ma, Wenbin Lan, Qun Liu. Platycodon D-induced A549 Cell Apoptosis through RRM1-Regulated p53/VEGF/
MMP2 Pathway. Anti-Cancer Agents in Medicinal Chemistry 2022; 22(13): 2458 doi: 10.2174/1871520622666220128095355
|
| 26 |
Ramon Andrade Bezerra de Mello. Polimorfismos genéticos e carcinoma de pulmão de células não pequenas: os paradigmas do futuro. Einstein (São Paulo) 2014; 12(4): 524 doi: 10.1590/S1679-45082014RB2906
|
| 27 |
Zhong-Yi Dong, Hao-Ran Zhai, Qing-Yi Hou, Jian Su, Si-Yang Liu, Hong-Hong Yan, Yang-Si Li, Zhi-Yong Chen, Wen-Zhao Zhong, Yi-Long Wu. Mixed Responses to Systemic Therapy Revealed Potential Genetic Heterogeneity and Poor Survival in Patients with Non-Small Cell Lung Cancer. The Oncologist 2017; 22(1): 61 doi: 10.1634/theoncologist.2016-0150
|
| 28 |
Behnoush Abedi-Ardekani, Nazir Ahmad Dar, Mohammad Muzaffar Mir, Showkat Ahmad Zargar, M Muqbool Lone, Ghyslaine Martel-Planche, Stéphanie Villar, Mounia Mounawar, Farrokh Saidi, Reza Malekzadeh, Pierre Hainaut. Epidermal growth factor receptor (EGFR) mutations and expression in squamous cell carcinoma of the esophagus in central Asia. BMC Cancer 2012; 12(1) doi: 10.1186/1471-2407-12-602
|
| 29 |
Deniz A. Bölükbas, Stefan Datz, Charlotte Meyer‐Schwickerath, Carmela Morrone, Ali Doryab, Dorothee Gößl, Malamati Vreka, Lin Yang, Christian Argyo, Sabine H. van Rijt, Michael Lindner, Oliver Eickelberg, Tobias Stoeger, Otmar Schmid, Sandra Lindstedt, Georgios T. Stathopoulos, Thomas Bein, Darcy E. Wagner, Silke Meiners. Organ‐Restricted Vascular Delivery of Nanoparticles for Lung Cancer Therapy. Advanced Therapeutics 2020; 3(7) doi: 10.1002/adtp.202000017
|
| 30 |
Béla Papp, Jean-Philippe Brouland, Atousa Arbabian, Pascal Gélébart, Tünde Kovács, Régis Bobe, Jocelyne Enouf, Nadine Varin-Blank, Ágota Apáti. Endoplasmic Reticulum Calcium Pumps and Cancer Cell Differentiation. Biomolecules 2012; 2(1): 165 doi: 10.3390/biom2010165
|